PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ecco-jcc/jjab071
?:doi
?:hasPublicationType
?:journal
  • Journal of Crohn\'s & colitis
is ?:pmid of
?:pmid
?:pmid
  • 33884425
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all